Company · CIK 0001395937 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Syndax Pharmaceuticals Inc · SNDX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 SForm 4 → | Jul 9, 4:54 pm EDT | Michael A MetzgerChief Executive Officer, Director | 32,375 | $24.24 | $784,776 | 484,843 | −6.26% | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 9, 4:54 pm EDT | Michael A MetzgerChief Executive Officer, Director | 32,375 | $6.38 | $206,553 | 517,218 | — | 10b5-1 |
| Jun 11, 2026 SForm 4 → | Jun 12, 5:09 pm EDT | Nicholas A.J. BotwoodHead of R&D, CMO | 65,515 | $18.07 | $1,183,643 | 60,885 | −51.8% | 10b5-1 |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:09 pm EDT | Nicholas A.J. BotwoodHead of R&D, CMO | 53,750 | $13.82 | $742,825 | 92,120 | — | 10b5-1 |
| Jan 31, 2019 JForm 4 → | Feb 8, 4:27 pm EST | Richard P SheaChief Financial Officer | 2,521 | $4.76 | $12,000 | 4,215 | — | plan? late |
| Jan 31, 2019 JForm 4 → | Feb 8, 4:27 pm EST | Michael L. MeyersSVP, Chief Medical Officer | 3,720 | $4.76 | $17,707 | 6,118 | — | plan? late |
| Jan 31, 2019 JForm 4 → | Feb 8, 4:27 pm EST | Michael A MetzgerPresident and COO | 2,659 | $4.76 | $12,657 | 2,659 | — | plan? late |
| Oct 30, 2018 PForm 4 → | Nov 7, 4:02 pm EST | Michael L. MeyersSVP, Chief Medical Officer | 200 | $4.79 | $958 | 2,398 | +9.10% | plan? late |
| Jun 18, 2018 JForm 4 → | Jun 20, 7:48 pm EDT | BVF PARTNERS L P/IL +610% Owner | 2,000,000 | — | — | 85,038 | — | plan? |
| Apr 3, 2018 SForm 4 → | Apr 3, 4:42 pm EDT | Peter OrdentlichChief Scientific Officer | 7,500 | $15.00 | $112,500 | 0 | −100% | plan? |
| Apr 3, 2018 MForm 4 → | Apr 3, 4:42 pm EDT | Peter OrdentlichChief Scientific Officer | 7,500 | $3.08 | $23,100 | 7,500 | — | plan? |
| May 17, 2017 SForm 4 → | May 19, 11:27 am EDT | Peter OrdentlichChief Scientific Officer | 5,000 | $15.00 | $75,000 | 0 | −100% | plan? |
| May 17, 2017 MForm 4 → | May 19, 11:27 am EDT | Peter OrdentlichChief Scientific Officer | 732 | $3.08 | $2,255 | 5,000 | — | plan? |
| Mar 20, 2017 DForm 4 → | Mar 22, 1:37 pm EDT | Ivor RoystonDirector | 125,000 | $13.75 | $1,718,750 | 625,545 | — | plan? |
| Mar 8, 2016 CForm 4 → | Mar 9, 4:42 pm EST | MPM BioVentures IV QP LP +910% Owner | 2,168,691 | — | — | 2,168,691 | — | plan? |
| Mar 8, 2016 PForm 4 → | Mar 8, 6:38 pm EST | Ivor RoystonDirector | 150,000 | $12.00 | $1,800,000 | 750,545 | +25.0% | plan? |
| Mar 8, 2016 CForm 4 → | Mar 8, 6:38 pm EST | Ivor RoystonDirector | 600,545 | — | — | 600,545 | — | plan? |
| Mar 8, 2016 CForm 4 → | Mar 8, 6:37 pm EST | Luke EvninDirector, 10% Owner | 2,168,691 | — | — | 2,168,691 | — | plan? |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:52 am EST | DP VI Associates, L.P. +4Director, 10% Owner | 13,925 | — | — | 13,925 | — | plan? |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:47 am EST | Domain Partners VI, L.P. +410% Owner | 1,743,854 | — | — | 1,743,854 | — | plan? |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:41 am EST | DP VIII Associates, L.P. +510% Owner | 5,641 | — | — | 5,641 | — | plan? |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:31 am EST | Domain Partners VIII, L.P. +510% Owner | 761,062 | — | — | 761,062 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 MForm 4 → | Jul 9, 4:54 pm EDT | Michael A MetzgerChief Executive Officer, Director | 32,375 | — | — | 0 | — | 10b5-1 |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:09 pm EDT | Nicholas A.J. BotwoodHead of R&D, CMO | 53,750 | — | — | 0 | — | 10b5-1 |
| Feb 6, 2019 AForm 4 → | Feb 8, 4:28 pm EST | Peter OrdentlichChief Scientific Officer | 80,000 | — | — | 80,000 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 4:28 pm EST | Briggs MorrisonChief Executive Officer, Director | 354,000 | — | — | 354,000 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 4:27 pm EST | Richard P SheaChief Financial Officer | 91,200 | — | — | 91,200 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 4:27 pm EST | Michael L. MeyersSVP, Chief Medical Officer | 104,325 | — | — | 104,325 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 4:27 pm EST | Michael A MetzgerPresident and COO | 240,000 | — | — | 240,000 | — | |
| Sep 25, 2018 AForm 4 → | Sep 27, 5:42 pm EDT | Jennifer JarrettDirector | 35,000 | — | — | 35,000 | — | |
| Sep 25, 2018 AForm 4 → | Sep 27, 5:42 pm EDT | William MeuryDirector | 35,000 | — | — | 35,000 | — | |
| Jun 18, 2018 JForm 4 → | Jun 20, 7:48 pm EDT | BVF PARTNERS L P/IL +610% Owner | 2,000,000 | — | — | 188,746 | — | |
| May 23, 2018 AForm 4 → | May 25, 9:00 am EDT | Henry ChenDirector | 14,000 | — | — | 14,000 | — | |
| May 23, 2018 AForm 4 → | May 25, 9:00 am EDT | Fabrice EgrosDirector | 14,000 | — | — | 14,000 | — | |
| May 23, 2018 AForm 4 → | May 25, 9:00 am EDT | Luke EvninDirector, 10% Owner | 14,000 | — | — | 14,000 | — | |
| May 23, 2018 AForm 4 → | May 25, 9:00 am EDT | Keith KatkinDirector | 14,000 | — | — | 14,000 | — | |
| May 23, 2018 AForm 4 → | May 25, 8:59 am EDT | Pierre LegaultDirector | 14,000 | — | — | 14,000 | — | |
| May 23, 2018 AForm 4 → | May 25, 8:59 am EDT | Dennis PodlesakDirector | 14,000 | — | — | 14,000 | — | |
| Apr 3, 2018 MForm 4 → | Apr 3, 4:42 pm EDT | Peter OrdentlichChief Scientific Officer | 7,500 | — | — | 0 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 4:04 pm EST | Richard P SheaChief Financial Officer | 48,000 | — | — | 48,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 4:04 pm EST | Peter OrdentlichChief Scientific Officer | 40,000 | — | — | 40,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 4:04 pm EST | Briggs MorrisonChief Executive Officer, Director | 200,000 | — | — | 200,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 4:04 pm EST | Michael L. MeyersSVP, Chief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 4:04 pm EST | Michael A MetzgerPresident and COO | 125,000 | — | — | 125,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:01 pm EST | Dennis PodlesakDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:01 pm EST | Pierre LegaultDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:01 pm EST | Keith KatkinDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:00 pm EST | Luke EvninDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:00 pm EST | Fabrice EgrosDirector | 10,000 | — | — | 10,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:00 pm EST | Henry ChenDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2017 MForm 4 → | May 19, 11:27 am EDT | Peter OrdentlichChief Scientific Officer | 732 | — | — | 0 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:27 am EDT | George W. Sledge Jr.Director | 5,000 | — | — | 5,000 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:26 am EDT | Dennis PodlesakDirector | 15,000 | — | — | 5,000 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:26 am EDT | Pierre LegaultDirector | 15,000 | — | — | 5,000 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:26 am EDT | Keith KatkinDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:26 am EDT | Luke EvninDirector, 10% Owner | 15,000 | — | — | 5,000 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:26 am EDT | Fabrice EgrosDirector | 15,000 | — | — | 5,000 | — | |
| May 17, 2017 AForm 4 → | May 19, 11:26 am EDT | Henry ChenDirector | 15,000 | — | — | 5,000 | — | |
| Mar 29, 2017 AForm 4 → | Mar 31, 4:46 pm EDT | Keith KatkinDirector | 25,000 | — | — | 25,000 | — | |
| Feb 13, 2017 AForm 4 → | Feb 15, 10:32 am EST | Richard P SheaChief Financial Officer | 125,000 | — | — | 125,000 | — | |
| Feb 6, 2017 AForm 4 → | Feb 8, 2:13 pm EST | Peter OrdentlichChief Scientific Officer | 20,000 | — | — | 20,000 | — | |
| Feb 6, 2017 AForm 4 → | Feb 8, 2:13 pm EST | Briggs MorrisonChief Executive Officer, Director | 160,000 | — | — | 160,000 | — | |
| Feb 6, 2017 AForm 4 → | Feb 8, 2:13 pm EST | Michael L. MeyersSVP, Chief Medical Officer | 66,100 | — | — | 66,100 | — | |
| Feb 6, 2017 AForm 4 → | Feb 8, 2:13 pm EST | Michael A MetzgerPresident and COO | 95,000 | — | — | 95,000 | — | |
| Jan 4, 2017 AForm 4 → | Jan 5, 5:05 pm EST | Pierre LegaultDirector | 20,000 | — | — | 20,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | Henry ChenDirector | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | George W. Sledge Jr.Director | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | Richard P SheaDirector | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | Ivor RoystonDirector | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | Dennis PodlesakDirector | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | Luke EvninDirector, 10% Owner | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:25 pm EDT | Fabrice EgrosDirector | 8,000 | — | — | 8,000 | — | |
| Oct 31, 2016 AForm 4 → | Nov 2, 4:44 pm EDT | Kim P. KamdarDirector, 10% Owner | 8,000 | — | — | 8,000 | — | |
| Mar 8, 2016 CForm 4 → | Mar 9, 4:42 pm EST | MPM BioVentures IV QP LP +910% Owner | 2,168,691 | — | — | 0 | — | |
| Mar 8, 2016 CForm 4 → | Mar 8, 6:38 pm EST | Ivor RoystonDirector | 600,545 | — | — | 0 | — | |
| Mar 8, 2016 CForm 4 → | Mar 8, 6:37 pm EST | Luke EvninDirector, 10% Owner | 2,168,691 | — | — | 0 | — | |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:52 am EST | DP VI Associates, L.P. +4Director, 10% Owner | 13,925 | — | — | 0 | — | |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:47 am EST | Domain Partners VI, L.P. +410% Owner | 1,743,854 | — | — | 0 | — | |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:41 am EST | DP VIII Associates, L.P. +510% Owner | 5,641 | — | — | 0 | — | |
| Mar 8, 2016 CForm 4 → | Mar 8, 11:31 am EST | Domain Partners VIII, L.P. +510% Owner | 761,062 | — | — | 0 | — |